EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 42 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,679,000 | -34.4% | 475,000 | -7.1% | 0.71% | -15.2% |
| Q4 2017 | $7,135,000 | +24.7% | 511,469 | -1.7% | 0.84% | +2.4% |
| Q3 2017 | $5,723,000 | +88.0% | 520,269 | +35.0% | 0.82% | +58.0% |
| Q2 2017 | $3,044,000 | -31.0% | 385,301 | 0.0% | 0.52% | -40.1% |
| Q1 2017 | $4,412,000 | -1.7% | 385,301 | 0.0% | 0.86% | -24.0% |
| Q4 2016 | $4,489,000 | -10.3% | 385,301 | +3.1% | 1.14% | +39.6% |
| Q3 2016 | $5,002,000 | +67.5% | 373,568 | +147.9% | 0.81% | +4.9% |
| Q2 2016 | $2,987,000 | +20.7% | 150,716 | +2.2% | 0.78% | +44.8% |
| Q1 2016 | $2,474,000 | – | 147,514 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |